Could a dash of magnesium in epidurals help new moms avoid catheters?
NCT ID NCT06442995
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding magnesium sulfate to the standard epidural pain medicine (morphine) can reduce the chance of urinary retention after a C-section. About 1 in 3 women have trouble urinating after surgery, often needing a catheter. The trial will compare magnesium plus morphine against morphine alone in 290 women. If successful, it could offer a simple way to improve recovery and comfort.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
magnesium sulfate
What this could lead to
If it works, this could offer a simple, low-cost way to prevent urinary retention after C-section, reducing the need for catheters and improving recovery.
What could go wrong
This is a single-center Phase 4 trial with 290 participants, so results may not apply broadly. The benefit seen in a prior retrospective study may not hold up in this more rigorous test.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URINARY RETENTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chu Reims
RECRUITINGReims, 51092, France
Contact Phone: •••-•••-•••• Email: •••••@•••••